CCAAT/Enhancer-Binding_NP Protein-alpha_NP Is_VBZ Induced_JJ during_IN the_DT Early_NP Stages_NP of_IN Kaposi_NP 's_POS Sarcoma-Associated_NP Herpesvirus_NP (_( KSHV_NP )_) Lytic_NP Cycle_NP Reactivation_NP and_CC Together_RB with_IN the_DT KSHV_NP Replication_NP and_CC Transcription_NP Activator_NP (_( RTA_NP )_) Cooperatively_NP Stimulates_VBZ the_DT Viral_NP RTA_NP ,_, MTA_NP ,_, and_CC PAN_NP Promoters_NP During_IN the_DT immediate-early_JJ (_( IE_NP )_) phase_NN of_IN reactivation_NN from_IN latency_NN ,_, the_DT Kaposi_NP 's_POS sarcoma-associated_JJ herpesvirus_NN (_( KSHV_NP )_) replication_NN and_CC transcription_NN activator_NN protein_NN (_( RTA_NP )_) (_( or_CC ORF50_NP )_) is_VBZ thought_VBN to_TO be_VB the_DT most_RBS critical_JJ trigger_NN that_WDT upregulates_VBZ expression_NN of_IN many_JJ downstream_JJ viral_JJ lytic_JJ cycle_NN genes_NNS ,_, including_VBG the_DT delayed-early_JJ (_( DE_NN )_) gene_NN encoding_VBG the_DT replication-associated_JJ protein_NN (_( RAP_NP )_) (_( or_CC K8_NP )_) ._SENT RAP_NN physically_RB interacts_VBZ with_IN and_CC stabilizes_VBZ the_DT cellular_JJ transcription_NN factor_NN CCAAT/enhancer-binding_NP protein-alpha_NP (_( C/EBPalpha_NP )_) ,_, leading_VBG to_TO upregulated_JJ expression_NN of_IN the_DT cellular_JJ C/EBPalpha_NP and_CC p21CIP-1_JJ proteins_NNS followed_VBN by_IN G0/G1_JJ cell_NN cycle_NN arrest_NN ._SENT Furthermore_RB ,_, RTA_NP also_RB interacts_VBZ with_IN C/EBPalpha_NP ,_, and_CC both_DT RAP_NP and_CC RTA_NP cooperate_VBP with_IN C/EBPalpha_NP to_TO activate_VB the_DT RAP_NP promoter_NN through_IN binding_VBG to_TO a_DT strong_JJ proximal_JJ C/EBP_NP binding_JJ site_NN that_WDT also_RB serves_VBZ as_IN an_DT RTA-responsive_JJ element_NN (_( RRE_NP )_) ._SENT Here_RB we_PP show_VBP that_IN C/EBPalpha_NP also_RB activates_VBZ the_DT IE_NP RTA_NP promoter_NN in_IN transient-cotransfection_NN reporter_NN gene_NN assays_NNS and_CC that_DT addition_NN of_IN either_DT RTA_NP or_CC RAP_NP enhances_VBZ the_DT effect_NN ._SENT Electrophoretic_JJ mobility_NN shift_NN assay_NN and_CC deletion_NN analysis_NN revealed_VBD three_CD C/EBP_NP binding_JJ sites_NNS that_WDT mediate_VBP cooperative_JJ transactivation_NN of_IN the_DT RTA_NP promoter_NN by_IN C/EBPalpha_NP and_CC RTA_NP ._SENT Furthermore_RB ,_, chromatin_NN immunoprecipitation_NN assay_NN results_NNS showed_VBD that_IN the_DT endogenous_JJ C/EBPalpha_NP ,_, RTA_NP ,_, and_CC RAP_NP proteins_VBZ all_DT associate_NN with_IN RTA_NP promoter_NN sequences_NNS in_IN tetradecanoyl_NN phorbol_NN acetate-induced_JJ primary_JJ effusion_NN lymphoma_NN (_( PEL_NP )_) cells_NNS ._SENT Induction_NN of_IN endogenous_JJ KSHV_NP RTA_NP mRNA_NP in_IN PEL_NP cells_NNS by_IN exogenously_RB introduced_VBN C/EBPalpha_NP was_VBD confirmed_VBN by_IN reverse_JJ transcription-PCR_NN analysis_NN and_CC by_IN double-label_NN indirect_JJ immunofluorescence_NN assays_NNS ._SENT Reciprocally_RB ,_, expression_NN of_IN exogenous_JJ RTA_NP also_RB led_VBD to_TO an_DT increase_NN of_IN endogenous_JJ C/EBPalpha_NP expression_NN that_WDT could_MD be_VB detected_VBN by_IN Western_JJ immunoblot_NN assays_NNS even_RB in_IN KSHV-negative_NP DG75_NP cells_NNS ._SENT Cotransfected_NP RTA_NP also_RB increased_VBD positive_JJ C/EBPalpha_NP autoregulation_NN of_IN the_DT C/EBPalpha_NP promoter_NN in_IN transient-cotransfection_NN reporter_NN gene_NN assays_NNS ._SENT Finally_RB ,_, C/EBPalpha_NP proved_VBD to_TO strongly_RB activate_VB the_DT promoters_NNS of_IN two_CD other_JJ KSHV_NP DE_NN genes_NNS encoding_VBG PAN_NP (_( polyadenylated_VBN nuclear_JJ )_) RNA_NP and_CC MTA_NP (_( ORF57_NP )_) ,_, which_WDT was_VBD again_RB mediated_VBN by_IN C/EBP_NP binding_JJ sites_NNS that_WDT also_RB contribute_VBP to_TO RTA_NP activation_NN ._SENT Overall_RB ,_, these_DT results_NNS support_VBP a_DT model_NN in_IN which_WDT the_DT cellular_JJ transcription_NN factor_NN C/EBPalpha_NP and_CC RTA:C/EBPalpha_NP interactions_NNS play_VBP important_JJ roles_NNS both_CC upstream_JJ and_CC downstream_JJ of_IN the_DT two_CD major_JJ KSHV_NP regulatory_JJ proteins_NNS RTA_NP and_CC RAP_NP during_IN the_DT early_JJ stages_NNS of_IN lytic_JJ cycle_NN reactivation_NN ._SENT Latent_JJ infection_NN with_IN Kaposi_NP 's_POS sarcoma-associated_JJ herpesvirus_NN (_( KSHV_NP )_) is_VBZ detected_VBN in_IN the_DT spindle_NN cells_NNS of_IN all_DT forms_NNS of_IN KS_NP ,_, as_RB well_RB as_IN in_IN plasmablast-like_JJ cells_NNS of_IN AIDS-associated_JJ multicentric_JJ Castleman_NP 's_POS disease_NN and_CC primary_JJ effusion_NN lymphoma_NN (_( PEL_NP )_) ._SENT Genome_NN analysis_NN revealed_VBD that_IN KSHV_NP belongs_VBZ to_TO the_DT gamma-2_JJ herpesvirus_NN subfamily_NN and_CC is_VBZ related_VBN to_TO Epstein-Barr_NP virus_NN (_( EBV_NP )_) ._SENT Based_VBN on_IN the_DT kinetics_NN of_IN gene_NN expression_NN after_IN viral_JJ reactivation_NN ,_, KSHV-encoded_NP genes_NNS are_VBP classified_VBN into_IN four_CD broad_JJ categories_NNS :_: latent_JJ ,_, immediate-early_RB (_( IE_NP )_) ,_, delayed-early_RB (_( DE_NP )_) ,_, and_CC late_RB ._SENT Several_JJ PEL_NP cell_NN lines_NNS carrying_VBG multicopy_JJ KSHV_NP episomes_NNS have_VBP been_VBN established_VBN ,_, and_CC virus_NN derived_VBN from_IN them_PP can_MD convert_VB dermal_JJ microvascular_JJ endothelial_JJ cells_NNS (_( DMVECs_NP )_) into_IN KS-like_JJ spindle_NN cells_NNS ._SENT Only_RB latent-state_JJ KSHV_NP proteins_NNS ,_, including_VBG LANA1_NP ,_, v-CYC-D_NN ,_, v-FLIP_NN ,_, and_CC K15_NP (_( or_CC LAMP_NP )_) ,_, are_VBP expressed_VBN in_IN the_DT majority_NN of_IN PEL_NP cells_NNS ,_, KS_NP spindle_NN cells_NNS ,_, and_CC infected_JJ DMVECs_NP ._SENT However_RB ,_, treatment_NN with_IN tetradecanoyl_NN phorbol_NN acetate_NN (_( TPA_NP )_) or_CC sodium_NN butyrate_NN can_MD disrupt_VB the_DT latency_NN of_IN KSHV_NP infection_NN ,_, especially_RB in_IN PEL_NP cells_NNS ,_, and_CC induce_VB lytic_JJ viral_JJ replication_NN in_IN a_DT subset_NN of_IN the_DT cells_NNS ._SENT Induction_NN of_IN several_JJ transcripts_NNS ,_, including_VBG those_DT from_IN the_DT major_JJ RTA_NP (_( or_CC ORF50_NP )_) ,_, ORF45_NP ,_, and_CC ORF-K4.2_NP promoters_NNS as_RB well_RB as_IN a_DT minor_JJ RAP_NN (_( or_CC K8_NP )_) promoter_NN of_IN KSHV_NP have_VBP been_VBN detected_VBN within_IN 4_CD h_NN after_IN lytic_JJ cycle_NN induction_NN in_IN the_DT presence_NN of_IN cycloheximide_NN ,_, and_CC therefore_RB these_DT genes_NNS have_VBP been_VBN defined_VBN as_IN the_DT likely_JJ IE_NP regulatory_JJ genes_NNS of_IN KSHV_NP ._SENT The_DT KSHV-encoded_NP RTA_NP protein_NN is_VBZ generally_RB considered_VBN to_TO function_VB as_IN the_DT principal_JJ molecular_JJ switch_NN converting_VBG infected_JJ cells_NNS from_IN a_DT latent_JJ state_NN into_IN the_DT lytic_JJ cycle_NN by_IN specific_JJ transcriptional_JJ activation_NN of_IN many_JJ downstream_JJ KSHV_NP promoters_NNS ._SENT The_DT 120-kDa_NP RTA_NP protein_NN (_( 691_CD amino_NN acids_NNS [_SYM aa_NN ]_SYM )_) is_VBZ a_DT homologue_NN of_IN the_DT EBV_NP DNA-binding_NP transactivator_NN RTA_NP (_( or_CC BRLF1_NP )_) ,_, which_WDT both_CC play_VB crucial_JJ roles_NNS as_IN the_DT triggers_NNS of_IN complete_JJ lytic_JJ reactivation_NN from_IN latency_NN ._SENT KSHV_NP RTA_NP transactivates_VBZ various_JJ downstream_JJ KSHV_NP lytic_JJ cycle_NN promoters_NNS ,_, including_VBG those_DT for_IN RAP_NP (_( a_DT positional_JJ homologue_NN of_IN EBV_NP ZTA_NP )_) ,_, KSHV_NP MTA_NP (_( or_CC ORF57_JJ a_DT homologue_NN of_IN EBV_NP MTA_NP )_) ,_, vIL6_NP ,_, vMIP_NN (_( or_CC vCCL_NN )_) ,_, K12_NP (_( or_CC Kaposin_NP )_) ,_, vOX2/GPCR_NN ,_, and_CC PAN_NP (_( polyadenylated_VBN nuclear_JJ )_) (_( or_CC T1.1_NP )_) RNA_NP (_( ,_, -_: ,_, ,_, ,_, ,_, )_) ._SENT In_IN at_IN least_JJS some_DT target_NN promoters_NNS (_( e.g._FW ,_, PAN_NP ,_, K12_NP ,_, and_CC vIL6_NN )_) ,_, RTA_NP clearly_RB functions_NNS by_IN direct_JJ DNA_NN binding_VBG to_TO specific_JJ type_NN II_NP RTA-responsive_NP elements_NNS (_( RREs_NP )_) ._SENT Although_IN Lukac_NP et_FW al._FW reported_VBD that_IN baculovirus-expressed_JJ RTA_NP also_RB binds_VBZ to_TO the_DT MTA_NP and_CC RAP_NP RRE_NP motifs_NNS in_IN electrophoretic_JJ mobility_NN shift_NN assay_NN (_( EMSA_NP )_) experiments_NNS ,_, we_PP observed_VBD that_IN in_IN vitro-translated_JJ RTA_NP does_VBZ not_RB bind_VB directly_RB to_TO the_DT type_NN I_PP RAP_NP RRE_NP ._SENT Instead_RB ,_, RTA_NP activates_VBZ RAP_NP expression_NN through_IN an_DT interaction_NN with_IN CCAAT/enhancer-binding_NP protein-alpha_NP (_( C/EBPalpha_NP )_) ,_, which_WDT itself_PP directly_RB binds_VBZ to_TO the_DT RRE_JJ site_NN and_CC activates_VBZ the_DT RAP_NP promoter_NN ._SENT Furthermore_RB ,_, a_DT strong_JJ physical_JJ interaction_NN was_VBD demonstrated_VBN between_IN C/EBPalpha_NP and_CC RTA_NP that_WDT requires_VBZ basic_JJ residues_NNS in_IN the_DT RTA_NP DNA-binding_NP domain_NN (_( DBD_NN )_) between_IN aa_NN 151_CD and_CC 273_CD ._SENT RTA_NP has_VBZ also_RB been_VBN reported_VBN to_TO activate_VB target_NN gene_NN expression_NN at_IN another_DT type_NN I_PP RRE_VBZ within_IN the_DT MTA_NP promoter_NN via_IN a_DT functional_JJ interaction_NN with_IN the_DT cellular_JJ CBF1_NN (_( or_CC RBP-Jkappa_NP )_) DNA_NN binding_VBG factor_NN ,_, a_DT target_NN of_IN the_DT Notch_NP signaling_VBG pathway_NN that_WDT also_RB plays_VBZ an_DT important_JJ role_NN in_IN EBNA2-mediated_JJ functions_NNS during_IN EBV_NP latency_NN ._SENT Previous_JJ studies_NNS have_VBP suggested_VBN that_IN KSHV_NP RTA_NP positively_RB autoregulates_VBZ its_PP$ own_JJ promoter_NN in_IN reporter_NN gene_NN cotransfection_NN assays_NNS in_IN 293_CD cells_NNS ._SENT In_IN addition_NN ,_, a_DT consensus_NN motif_NN at_IN position_NN -220/-213_CD in_IN the_DT RTA_NP promoter_NN was_VBD shown_VBN to_TO bind_VB to_TO the_DT OCT1_JJ protein_NN and_CC was_VBD interpreted_VBN to_TO be_VB important_JJ for_IN RTA-mediated_JJ autoregulation_NN in_IN 293L_JJ cells_NNS ._SENT However_RB ,_, because_IN of_IN our_PP$ evidence_NN that_IN KSHV_NP RTA_NP physically_RB interacts_VBZ with_IN C/EBPalpha_NP and_CC the_DT predicted_VBN presence_NN of_IN C/EBP_NP sites_NNS in_IN the_DT RTA_NP promoter_NN ,_, we_PP wished_VBD to_TO evaluate_VB other_JJ potential_JJ mechanisms_NNS for_IN controlling_VBG expression_NN of_IN the_DT RTA_NP lytic_JJ cycle_NN trigger_NN protein_NN ._SENT C/EBPalpha_NP was_VBD the_DT first_JJ identified_VBN member_NN of_IN the_DT leucine_NN zipper_NN family_NN of_IN transcription_NN factors_NNS ,_, which_WDT includes_VBZ c-JUN_NP ,_, c-FOS_NP ,_, ATF_NP ,_, CREB_NP ,_, and_CC EBV_NP ZTA_NP ._SENT Members_NNS of_IN this_DT family_NN bind_NN to_TO specific_JJ DNA_NN elements_NNS as_IN homodimers_NNS or_CC heterodimers_NNS through_IN the_DT conserved_VBN bZIP_NN domain_NN located_VBN at_IN the_DT C_NP terminus_NN and_CC modulate_VB gene_NN expression_NN through_IN an_DT N-terminal_JJ activation_NN domain_NN ._SENT Numerous_JJ studies_NNS have_VBP shown_VBN that_IN C/EBPalpha_NP promotes_VBZ differentiation_NN and_CC inhibits_VBZ cell_NN proliferation_NN through_IN multiple_JJ molecular_JJ pathways_NNS leading_VBG to_TO G1_NP cell_NN cycle_NN arrest_NN ,_, including_VBG elevating_VBG the_DT level_NN of_IN p21CIP-1/WAF-1_JJ protein_NN by_IN both_DT directly_RB binding_JJ to_TO and_CC activating_VBG the_DT p21CIP-1_JJ promoter_NN and_CC stabilizing_VBG p21_NN through_IN a_DT protein-protein_NN interaction_NN ._SENT C/EBPalpha_NP also_RB inhibits_VBZ E2F_NP transcription_NN of_IN genes_NNS ,_, including_VBG c-MYC_NP ,_, which_WDT is_VBZ involved_VBN in_IN DNA_NN synthesis_NN and_CC mitosis_NN through_IN direct_JJ interaction_NN with_IN retinoblastoma_NN (_( Rb_NP )_) and_CC Rb-like_JJ proteins_NNS ,_, as_RB well_RB as_IN directly_RB inhibiting_VBG CDK2_NP and_CC CDK4_NP ._SENT The_DT 35-kDa_NP KSHV-encoded_NP RAP_NP protein_NN (_( 237_CD aa_NN )_) is_VBZ also_RB a_DT bZIP-like_JJ protein_NN that_WDT targets_VBZ to_TO nuclear_JJ PML_NP oncogenic_JJ domains_NNS and_CC seems_VBZ to_TO play_VB an_DT important_JJ role_NN in_IN lytic_JJ cycle_NN viral_JJ DNA_NN replication_NN ._SENT Unlike_IN its_PP$ positional_JJ homologue_NN ZTA_NP ,_, the_DT major_JJ lytic_JJ cycle_NN trigger_NN protein_NN encoded_VBN by_IN EBV_NP ,_, RAP_NP alone_RB does_VBZ not_RB bind_VB to_TO any_DT known_VBN downstream_JJ KSHV_NP target_NN gene_NN promoters_NNS ,_, nor_CC does_VBZ it_PP act_VB alone_RB as_IN a_DT trigger_NN for_IN KSHV_NP lytic_JJ cycle_NN induction_NN ._SENT However_RB ,_, both_DT RAP_NP and_CC ZTA_NP display_VBP similar_JJ properties_NNS in_IN upregulating_VBG levels_NNS of_IN the_DT cellular_JJ C/EBPalpha_NP and_CC p21CIP-1_JJ proteins_NNS ,_, resulting_VBG in_IN G0/G1_JJ cell_NN cycle_NN arrest_NN during_IN progression_NN of_IN the_DT KSHV_NP or_CC EBV_NP lytic_JJ cycles_NNS ,_, respectively_RB ._SENT The_DT mechanism_NN of_IN C/EBPalpha_NP induction_NN was_VBD found_VBN to_TO involve_VB strong_JJ protein-protein_NN interactions_NNS between_IN C/EBPalpha_NP and_CC RAP_NP or_CC C/EBPalpha_NP and_CC ZTA_NP ,_, leading_VBG to_TO both_DT stabilization_NN of_IN C/EBPalpha_NP protein_NN and_CC cooperative_JJ transcriptional_JJ upregulation_NN of_IN the_DT cellular_JJ C/EBPalpha_NP and_CC p21_JJ promoters_NNS ._SENT C/EBPalpha_NP also_RB proved_VBD to_TO reciprocally_RB activate_VB viral_JJ RAP_NP and_CC ZTA_NP gene_NN expression_NN by_IN directly_RB binding_VBG to_TO strong_JJ promoter_NN proximal_JJ C/EBP_NP binding_JJ sites_NNS (_( ,_, ;_: F._NP Y._NP Wu_NP et_FW al._FW ,_, unpublished_JJ data_NNS )_) ._SENT In_IN the_DT present_JJ study_NN ,_, we_PP have_VBP asked_VBN whether_IN C/EBPalpha_NP might_MD also_RB play_VB a_DT role_NN in_IN activating_VBG KSHV_NP IE_NP gene_NN expression_NN and_CC have_VBP used_VBN EMSA_NP and_CC mutation_NN analysis_NN to_TO identify_VB three_CD C/EBPalpha_NP binding_JJ sites_NNS within_IN the_DT proximal_JJ 914-bp_NN RTA_NP promoter_NN ._SENT Cotransfection_NN of_IN a_DT series_NN of_IN deletion_NN mutant_NN or_CC mutated_VBN RTA-LUC_NP target_NN reporter_NN genes_NNS in_IN several_JJ cell_NN types_NNS was_VBD used_VBN to_TO evaluate_VB both_DT direct_JJ and_CC cooperative_JJ responsiveness_NN to_TO C/EBPalpha_NP ,_, RAP_NP ,_, and_CC RTA_NP ._SENT A_DT chromatin_NN immunoprecipitation_NN (_( ChIP_NP )_) assay_NN was_VBD employed_VBN to_TO investigate_VB whether_IN C/EBPalpha_NP ,_, RAP_NP ,_, and_CC RTA_NP associate_NN in_IN vivo_JJ with_IN the_DT RTA_NP promoter_NN in_IN KSHV_NP lytically_RB infected_VBD PEL_NP cells_NNS ._SENT We_PP then_RB also_RB tested_VBN the_DT ability_NN of_IN C/EBPalpha_NP to_TO upregulate_VB endogenous_JJ RTA_NP in_IN PEL_NP cells_NNS and_CC possible_JJ cooperative_JJ effects_NNS of_IN RTA_NP plus_CC C/EBPalpha_NP in_IN regulating_VBG the_DT cellular_JJ C/EBPalpha_NP promoter_NN ._SENT The_DT kinetics_NNS of_IN induction_NN of_IN C/EBPalpha_NP mRNA_NN and_CC protein_NN levels_NNS in_IN TPA-induced_NP PEL_NP cells_NNS were_VBD also_RB examined_VBN ._SENT Finally_RB ,_, we_PP searched_VBD for_IN C/EBP_NP binding_JJ sites_NNS and_CC investigated_VBD C/EBPalpha_NP responsiveness_NN ,_, C/EBPalpha_NP plus_CC RTA_NP cooperativity_NN ,_, and_CC in_IN vivo_JJ ChIP_NP associations_NNS in_IN two_CD other_JJ downstream_JJ KSHV_NP DE_NN promoters_NNS that_WDT are_VBP associated_VBN with_IN the_DT PAN_NP and_CC MTA_NP genes_NNS and_CC have_VBP been_VBN shown_VBN to_TO respond_VB strongly_RB to_TO RTA_NP ._SENT Cells_NNS and_CC plasmids_NNS ._SENT |_SYM HeLa_NP and_CC 293T_JJ cells_NNS were_VBD grown_VBN in_IN Dulbecco_NP 's_POS modified_JJ Eagle_NP 's_POS medium_NN (_( Invitrogen_NP ,_, Carlsbad_NP ,_, Calif._NP )_) containing_VBG 10_CD %_NN fetal_JJ bovine_JJ serum_NN in_IN a_DT humidified_VBN 5_CD %_NN CO2_JJ incubator_NN at_IN 37C_JJ ._SENT KSHV-positive_JJ human_JJ PEL_NP cells_NNS BCBL1_NP cells_NNS ,_, and_CC JSC1_JJ cells_NNS ,_, as_RB well_RB as_IN the_DT KSHV-negative_NP DG75_NP B-lymphoblast_NP cell_NN line_NN ,_, were_VBD grown_VBN in_IN RPMI_NP 1640_CD medium_NN (_( Invitrogen_NP )_) containing_VBG 10_CD %_NN fetal_JJ bovine_JJ serum_NN ._SENT For_IN KSHV_NP lytic_JJ cycle_NN induction_NN ,_, TPA_NP was_VBD added_VBN to_TO the_DT medium_NN at_IN a_DT final_JJ concentration_NN of_IN 20_CD ng/ml_NNS ._SENT Plasmids_NNS pSEW-C01_JJ ,_, pSEW-C02_JJ ,_, pJX15_JJ ,_, and_CC pCTC581a_NN expressing_VBG full-length_JJ human_JJ C/EBPalpha_NP ,_, Flag-tagged_NP C/EBPalpha_NP ,_, KSHV_NP RTA_NP ,_, and_CC Flag-tagged_NP KSHV_NP RAP_NP effector_NN genes_NNS driven_VBN by_IN CMV_NP or_CC SV2_NP promoter-enhancers_NNS were_VBD described_VBN previously_RB ._SENT Plasmid_NP pSEW-R03_NP encodes_VBZ the_DT RTA(1-377)_NP DBD_NN segment_NN ;_: plasmid_NP pSEW-R23_NP encodes_VBZ RTA(1-691Delta151-167)_NP with_IN an_DT in-frame_JJ internal_JJ deletion_NN from_IN position_NN 151_CD to_TO 167_CD ._SENT Reporter_NN plasmid_NN pGL3-FL(-914)_NN containing_VBG the_DT intact_JJ RTA(-914/+34)-LUC_NP reporter_NN gene_NN was_VBD kindly_RB provided_VBN by_IN Koichi_NP Yamanishi_NP ._SENT Deletion_NN derivatives_NNS of_IN the_DT full-length_JJ RTA-LUC_NP reporter_NN gene_NN were_VBD generated_VBN by_IN PCR_NP using_VBG RTA(-914/+34)-LUC_NP as_IN the_DT template_NN to_TO generate_VB RTA(-587/+20)-LUC_NP (_( in_IN pSEW-RP1_NN )_) ,_, RTA(-554/+20)-LUC_NP (_( pSEW-RP2_NN )_) ,_, RTA(-261/+20)-LUC_NP (_( pSEW-RP3_NN )_) ,_, RTA(-241/+20)-LUC_NP (_( pSEW-RP4_NN )_) ,_, and_CC RTA(-212/+20)-LUC_NP (_( pSEW-RP5_NN )_) or_CC by_IN PCR-based_JJ mutagenesis_NN using_VBG pSEW-RP4_NN or_CC pSEW-RP1_NN as_IN the_DT templates_NNS to_TO generate_VB mutants_NNS RTA(-241/+20_NP pm-48/-43)-LUC_NP (_( pSEW-RP6_NN )_) or_CC RTA(-587/+20_NP pm-48/-43)-LUC_NP (_( pSEW-RP7_JJ )_) ,_, in_IN which_WDT GCAATG_NP at_IN position_NN -48_CD to_TO -43_CD has_VBZ been_VBN changed_VBN to_TO GATATC_NP (_( throughout_IN this_DT work_NN ,_, mutated_VBN nucleotides_NNS are_VBP indicated_VBN in_IN boldface_JJ type_NN )_) ._SENT A_DT plasmid_NN encoding_VBG the_DT human_JJ C/EBPalpha(-500/+10)-LUC_NP reporter_NN gene_NN (_( pSEW-CP1_NN )_) contains_VBZ the_DT proximal_JJ C/EBPalpha_NP promoter_NN region_NN inserted_VBN into_IN a_DT minimal_JJ promoter_NN in_IN the_DT pGL3-Basic_JJ background_NN ,_, as_RB described_VBN previously_RB ._SENT The_DT PAN(-210/+15)-LUC_NP reporter_NN gene_NN contains_VBZ the_DT wild-type_JJ PAN_NP promoter_NN inserted_VBN into_IN the_DT pGL3-Basic_JJ background_NN (_( in_IN plasmid_NN pSEW-PP1_NN )_) and_CC point_VBP mutant_JJ derivatives_NNS PAN(-190/+15)-LUC_NN (_( pSEW-PP2_NN )_) ,_, PAN(-190/+15pm2A)-LUC_NP (_( pSEW-PP3_NN )_) ,_, PAN(-190/+15pm2B)-LUC_NP (_( pSEW-PP4_NN )_) ,_, PAN(-190/+15pm4A)-LUC_NP (_( pSEW-PP5_NN )_) ,_, and_CC PAN(-190/+15pm4B)-LUC_NP (_( pSEW-PP6_NP )_) (_( see_VB Fig._NN )_) Point_NP mutant_JJ reporter_NN gene_NN PAN(-190/+15RREm)-LUC_NP (_( in_IN plasmid_NN pSEW-PP7_JJ )_) contains_VBZ five_CD point_NN mutations_NNS within_IN the_DT RRE_JJ region_NN at_IN position_NN -61_CD to_TO -52_CD ,_, (_( GCTAACCTGT_NP to_TO TCTACCCGTG_NP )_) ._SENT A_DT set_NN of_IN MTA_NP promoter_NN reporter_NN plasmids_NNS expressing_VBG MTA(-160/+10)-LUC_NP ,_, MTA(-100/+10)-LUC_NP ,_, and_CC MTA(-60/+10)-LUC_NP in_IN pSEW-MP1_JJ ,_, pSEW-MP2_JJ ,_, and_CC pSEW-MP3_NN ,_, respectively_RB ,_, were_VBD generated_VBN by_IN PCR_NP amplification_NN from_IN BCBL1_NP DNA_NP ._SENT Point_NN mutant_JJ derivative_JJ pSEW-MP4_NN expressing_VBG MTA(-100/+10_NP pm_NN -94/-90)-LUC_NN in_IN which_WDT ACAAT_NP at_IN position_NN -94_CD to_TO -90_CD has_VBZ been_VBN changed_VBN to_TO TCTAG_NP was_VBD generated_VBN by_IN a_DT PCR-based_JJ method_NN using_VBG pSEW-MP2_NN as_IN the_DT template_NN ._SENT DNA_NP transfection_NN and_CC luciferase_NN assay_NN ._SENT |_SYM Transfection_NN of_IN HeLa_NP cells_NNS was_VBD performed_VBN with_IN 5_CD x_SYM 105_CD cells/sample_NN in_IN six-well_NN plates_NNS using_VBG Lipofectamine_NP (_( Invitrogen_NP )_) according_VBG to_TO the_DT Invitrogen_NP protocol_NN ._SENT BCBL1_NP and_CC DG75_NP B-lymphoblast_NP cell_NN lines_NNS (_( 107_CD cells/sample_NN )_) were_VBD transfected_VBN using_VBG the_DT electroporation_NN method_NN described_VBD previously_RB ._SENT Transfected_JJ cells_NNS were_VBD harvested_VBN at_IN 48_CD h_NN posttransfection_NN for_IN luciferase_NN assays_NNS as_RB described_VBN by_IN Wang_NP et_FW al._FW ._SENT All_DT samples_NNS also_RB received_VBD added_JJ CMV-betaGAL_NP expression_NN plasmid_NP DNA_NP as_IN an_DT internal_JJ control_NN for_IN transfection_NN variability_NN ,_, and_CC the_DT betaGAL_JJ activity_NN was_VBD found_VBN not_RB to_TO be_VB significantly_RB affected_VBN by_IN cotransfection_NN with_IN either_DT C/EBPalpha_NP ,_, RTA_NP ,_, or_CC RAP_NP or_CC combinations_NNS of_IN them_PP ._SENT Extraction_NN of_IN mRNA_NP and_CC RT-PCR_NP ._SENT |_SYM BCBL1_NP cells_NNS were_VBD transfected_VBN by_IN electroporation_NN ,_, and_CC mRNA_NN was_VBD extracted_VBN at_IN 40_CD h_NN posttransfection_NN using_VBG a_DT GenElute_NP Direct_NP mRNA_NP Miniprep_NP kit_NN (_( Sigma_NP )_) according_VBG to_TO the_DT product_NN instructions_NNS as_RB described_VBD previously_RB ._SENT The_DT purified_VBN mRNA_NN samples_NNS (_( 1_CD mug_NN )_) were_VBD incubated_VBN with_IN 1_CD U_NN of_IN DNase_NP I_NP (_( Invitrogen_NP )_) and_CC 10_CD mul_NN of_IN DNase_NP I_NP reaction_NN buffer_NN for_IN 15_CD min_NN at_IN 20C_JJ ._SENT Then_RB ,_, DNase_NP I_PP was_VBD inactivated_VBN by_IN adding_VBG 1_CD mul_NN of_IN 25_CD mM_NP EDTA_NP to_TO the_DT mixture_NN and_CC heating_NN for_IN 10_CD min_NN at_IN 65C_JJ ._SENT Reverse_JJ transcription_NN (_( RT_NP )_) was_VBD performed_VBN using_VBG avian_JJ myeloblastosis_NN virus_NN reverse_NN transcriptase_NN (_( Promega_NP )_) as_IN previously_RB described_VBN ,_, and_CC the_DT synthesized_VBN cDNA_NN samples_NNS were_VBD used_VBN as_IN templates_NNS for_IN PCRs_NNS using_VBG RTA_NP coding_VBG region_NN primers_NNS LGH4289_NP (_( 5'-GAACTACTCGAGATGGTCACTGGACTGTCCTATCC-3_NP '_POS )_) and_CC LGH4290_NP (_( 5'-TGACGAAGCTTCAGGTACCAGGTGTCGTGGTCG-3_NP '_POS )_) ._SENT The_DT cDNA_NP PCR_NP products_NNS (_( 915_CD bp_NN )_) were_VBD analyzed_VBN on_IN a_DT 1.2_CD %_NN agarose_NN gel_NN ._SENT IFA_NP ._SENT |_SYM Indirect_NN immunofluorescence_NN assay_NN (_( IFA_NP )_) was_VBD performed_VBN 24_CD h_NN after_IN BCBL1_NP cells_NNS were_VBD transfected_VBN or_CC induced_VBN by_IN TPA_NP using_VBG the_DT methanol_NN fixation_NN method_NN ._SENT Primary_JJ antibodies_NNS included_VBD rabbit_NN antipeptide_NN antiserum_NN against_IN KSHV_NP RTA_NP ,_, mouse_NN anti-Flag_NN monoclonal_NN antibody_NN (_( MAb_NP )_) (_( Sigma_NP ,_, St._NP Louis_NP ,_, Mo._NP )_) ,_, and_CC goat_NN (_( Santa_NP Cruz_NP ,_, Santa_NP Cruz_NP ,_, Calif._NP )_) or_CC rabbit_NN anti-C/EBPalpha_NN polyclonal_JJ antibody_NN (_( PAb_NP )_) ._SENT Secondary_JJ donkey-_NN or_CC goat-derived_JJ fluorescein_NN isothiocyanate_NN (FITC)-_NN or_CC rhodamine-conjugated_JJ anti-rabbit_NN or_CC anti-mouse_NN or_CC anti-goat_NN immunoglobulin_NN G_NP (_( Jackson_NP Pharmaceuticals_NP ,_, West_NP Grove_NP ,_, Pa._NP )_) was_VBD used_VBN to_TO detect_VB the_DT primary_JJ antibodies_NNS ._SENT Mounting_VBG solution_NN with_IN DAPI_NP (_( 4',6'-diamidino-2-phenylindole_NP )_) (_( Vector_NP Shield_NP )_) was_VBD used_VBN to_TO visualize_VB cellular_JJ DNA_NN ._SENT EMSA_NP ._SENT |_SYM C/EBPalpha_NP protein_NN samples_NNS used_VBN for_IN EMSA_NP were_VBD in_IN vitro_NP translated_VBN using_VBG the_DT TNT_NP Quick_NP Coupled_NP Transcription/Translation_NP system_NN (_( Promega_NP )_) according_VBG to_TO the_DT manufacturer_NN 's_POS procedures_NNS ,_, and_CC pBBV-C/EBPalpha_NP plasmid_NP DNA_NP was_VBD used_VBN as_IN the_DT template_NN ._SENT Annealed_VBN double-strand_NN oligonucleotides_NNS were_VBD radiolabeled_VBN with_IN [_SYM alpha-32P]dCTP_NN by_IN Klenow_NP DNA_NP polymerase_NN ._SENT For_IN EMSA_NP ,_, approximately_RB 50,000_CD cpm_NN of_IN the_DT 32P-labeled_JJ probe_NN and_CC 2_CD mul_NN of_IN in_IN vitro-translated_JJ C/EBPalpha_NP protein_NN were_VBD incubated_VBN for_IN 30_CD min_NN at_IN 20C_JJ in_IN a_DT binding_JJ system_NN containing_VBG 10_CD mM_NP HEPES_NP (_( pH_NN 7.5_CD )_) ,_, 50_CD mM_NP KCl_NP ,_, 1_CD mM_NP EDTA_NP ,_, 1_CD mM_NP dithiothreitol_NN ,_, 1_CD mM_NP phenylmethylsulfonyl_NN fluoride_NN ,_, 1_CD %_NN Triton_NP X-100_NP ,_, 5_CD %_NN glycerol_NN ,_, and_CC 2_CD mug_NN of_IN poly(dI-dC_NN )_) ._SENT For_IN supershift_NN experiments_NNS ,_, 0.5_CD mul_NN of_IN C/EBPalpha_NP rabbit_NN antiserum_NN or_CC RTA_NP rabbit_NN antiserum_NN against_IN an_DT RTA_NP epitope_NN between_IN aa_NN 527_CD and_CC 539_CD was_VBD added_VBN to_TO the_DT mixture_NN after_IN 30_CD min_NN and_CC allowed_VBD to_TO incubate_VB for_IN another_DT 30_CD min_NN before_IN gel_NN loading_NN ._SENT Samples_NNS were_VBD separated_VBN on_IN a_DT 4.5_CD %_NN polyacrylamide_NN gel_NN in_IN 1x_NP HEE_NP buffer_NN (_( 10_CD mM_NP HEPES_NP [_SYM pH_NN 7.5_CD ]_SYM ,_, 1_CD mM_NP EDTA_NP ,_, 0.5_CD mM_NP EGTA_NP )_) at_IN 150_CD V_CD at_IN 4C_JJ as_RB described_VBN previously_RB ._SENT The_DT gels_NNS were_VBD dried_VBN and_CC subjected_VBN to_TO autoradiography_NN with_IN Kodak_NP X-ray_NN film_NN ._SENT All_DT oligonucleotides_NNS used_VBN were_VBD purchased_VBN from_IN Qiagen_NP Operon_NP ._SENT The_DT following_VBG RTA_NP promoter_NN probes_NNS were_VBD used_VBN :_: LGH4341_NP (_( 5'-GATCTGGCGCTACAGTGGGTGATTTCTTCTACCACGG-3_NP '_POS )_) and_CC LGH4342_NP (_( 5'-GATCCCGTGGTAGAAGAAATCACCCACTGTAGCGCCA-3_NP '_POS )_) annealed_VBD to_TO form_VB probe_NN RP-1_NP ;_: LGH4343_NP (_( 5'-GATCTCATACATTGGTGGCACCCACAGGCCTGTTCCA-3_NP '_POS )_) and_CC LGH4344_NP (_( 5'-GATCTGGAACAGGCCTGTGGGTGCCACCAATGTATGA-3_NP '_POS )_) annealed_VBD to_TO form_VB probe_NN RP-2_NP ;_: LGH4345_NP (_( 5'-GATCGTGGTACCGAATGCCACAATCTGTGCCCTCCAG-3_NP '_POS )_) and_CC LGH4346_NP (_( 5'-GATCCTGGAGGGCACAGATTGTGGCATTCGGTACCAC-3_NP '_POS )_) annealed_VBD to_TO form_VB probe_NN RP-3_NP ;_: LGH4347_NP (_( 5'-GATCACAATTTTCATCTCCAATACCCGGAATTGGGAT-3_NP '_POS )_) and_CC LGH4348_NP (_( 5'-GATCATCCCAATTCCGGGTATTGGAGATGAAAATTGT-3_NP '_POS )_) annealed_VBD to_TO form_VB probe_NN RP-4_NP ;_: LGH4349_NP (_( 5'-GATCCCAGAAACCAGTAGCTGGGTGGCAATGACACGT-3_NP '_POS )_) and_CC LGH4350_NP (_( 5'-GATCACGTGTCATTGCCACCCAGCTACTGGTTTCTGG-3_NP '_POS )_) annealed_VBD to_TO form_VB probe_NN RP-5_NP ;_: LGH4363_NP (_( 5'-GATCCCAGAAACCAGTAGCTGGGTGGATATCACACGT-3_NP '_POS )_) and_CC LGH4364_NP (_( 5'-GATCACGTGTGATATCCACCCAGCTACTGGTTTCTGG-3_NP '_POS )_) annealed_VBD to_TO form_VB probe_NN RP-5M_NN ._SENT The_DT entire_JJ PAN_NP promoter_NN insert_NN from_IN PAN(-210/+15)-LUC_NP was_VBD isolated_VBN by_IN cleavage_NN with_IN SacI/HindIII_NP and_CC end_NN labeled_VBN to_TO obtain_VB probe_NN PAN-225_NN ._SENT The_DT PAN-1_JJ probe_NN was_VBD generated_VBN by_IN annealing_VBG oligonucleotides_NP LGH4971_NP (_( 5'-GATCATTAATGAAAGTTTATTAATGTTCATCCGT-3_NP '_POS )_) and_CC LGH4972_NP (_( 5'-GATCACGGATGAACATTAATAAACTTTCATTAAT-3_NP '_POS )_) ;_: probes_NNS PAN-2_NP ,_, PAN-2A_NP ,_, and_CC PAN-2B_NP were_VBD generated_VBN by_IN annealing_VBG LGH4973_NP and_CC LGH4974_NP ,_, LGH4990_NP and_CC LGH4991_NP ,_, and_CC LGH4992_NP and_CC LGH4993_NP ,_, respectively_RB ,_, which_WDT contain_VBP an_DT additional_JJ GATC_NN at_IN the_DT 5_CD '_POS ends_NNS (_( see_VB Fig._NN )_) ;_: probe_NN PAN-3_NP was_VBD generated_VBN by_IN annealing_VBG LGH4975_NP (_( 5'-GATCATGGAGTTTTCTTATGGATTATTAAGGGTCAGCTTGAAGG-3_NP '_POS )_) and_CC LGH4976_NP (_( 5'-GATCCCTTCAAGCTGACCCTTAATAATCCATAAGAAAACTCCAT-3_NP '_POS )_) ;_: probes_NNS PAN-4_NP ,_, PAN-4A_NP ,_, and_CC PAN-4B_NP were_VBD generated_VBN by_IN annealing_VBG LGH4977_JJ and_CC LGH4978_NP ,_, LGH4994_NP and_CC LGH4995_NP ,_, and_CC LGH4996_NP and_CC LGH4997_JJ ,_, respectively_RB ,_, which_WDT contain_VBP an_DT additional_JJ GATC_NN at_IN the_DT 5_CD '_POS ends_NNS (_( see_VB Fig._NN )_) ._SENT Probe_NN PAN-RRE_NP (_( 41_CD bp_NN )_) was_VBD described_VBN previously_RB ._SENT Probe_NN MTA-1_NP was_VBD generated_VBN by_IN annealing_VBG LGH4980_NP (_( 5'-GATCCTTCATTCCATTAGGGTGAGCGAAGTCACGGTAACACTTATGA-3_NP '_POS )_) and_CC LGH4981_NP (_( 5'-GATCTCATAAGTGTTACCGTGACTTCGCTCACCCTAATGGAATGAAG-3_NP '_POS )_) ;_: probe_NN MTA-2_NN was_VBD generated_VBN by_IN annealing_VBG LGH4982_NP (_( 5'-GATCGTCAGTGTTTTGCCAGCAAGTGTAACAATAATGTTCCCACGGC-3_NP '_POS )_) and_CC LGH4983_NP (_( 5'-GATCGCCGTGGGAACATTATTGTTACACTTGCTGGCAAAACACTGAC-3_NP '_POS )_) ;_: probe_NN MTA-3_NP was_VBD generated_VBN by_IN annealing_VBG LGH4984_NP (_( 5'-GATCCCATTTTTCGTTTGTGGTACCTGTGGGACTGGCCAGTTAATCC-3_NP '_POS )_) and_CC LGH4985_NP (_( 5'-GATCGGATTAACTGGCCAGTCCCACTGGTACCACAAACGAAAAATGG-3_NP '_POS )_) ;_: probe_NN MTA-2M_NP was_VBD generated_VBN by_IN annealing_VBG LGH5236_NP (_( 5'-GATCGTCAGTGTTTTGCCAGCAAGTGTATCTAGAATGTTCCCACGGC-3_NP '_POS )_) and_CC LGH5237_JJ (_( 5'-GATCGCCGTGGGAACATTCTAGATACACTTGCTGGCAAAACACTGAC-3_JJ '_'' )_) ._SENT ChIP_NN ._SENT |_SYM JSC1_NP or_CC BCBL1_NP PEL_NP cells_NNS were_VBD treated_VBN with_IN TPA_NP before_IN harvesting_VBG at_IN different_JJ time_NN points_NNS for_IN ChIP_NP assays_NNS as_RB described_VBD elsewhere_RB using_VBG rabbit_NN PAbs_NNS against_IN C/EBPalpha_NP ,_, KSHV_NP RTA_NP ,_, or_CC KSHV_NP RAP_NP or_CC mouse_NN MAb_NN against_IN EBV_NP ZTA_NP or_CC mouse_NN MAb_NN against_IN CHOP10_NP as_IN controls_NNS ._SENT Primers_NNS LGH4354_NP (_( 5'-GAACTACTCGAGCTGTGCCCTCCAGCTCTCAC-3_NP '_POS )_) and_CC LGH4355_NP (_( 5'-GGACGTAAGCTTACAGTATTCTCACAACAGAC-3_NP '_POS )_) ,_, specific_JJ for_IN a_DT 261-bp_JJ region_NN in_IN the_DT KSHV_NP RTA_NP promoter_NN from_IN -241_CD to_TO +20_NN ;_: primers_NNS LGH4973_NP (_( described_VBN for_IN EMSA_NP )_) and_CC LGH4998_NP (_( 5'-TGATCTAAGCTTCTGGGCAGTCCCAGTGCT-3_NP '_POS )_) ,_, specific_JJ for_IN a_DT 205-bp_JJ region_NN in_IN the_DT KSHV_NP PAN_NP promoter_NN from_IN -190_CD to_TO +_SYM 15_CD ;_: and_CC primers_NNS LGH4980_NN (_( described_VBN for_IN EMSA_NP )_) and_CC LGH4987_JJ (_( 5'-GATCGCGGGCTATTTTGGGAACCTGGCAGCCAGGTTATATAGTG-3_NP '_POS )_) ,_, specific_JJ for_IN a_DT 168-bp_JJ region_NN in_IN the_DT KSHV_NP MTA_NP promoter_NN from_IN -160_CD to_TO +8_NN ,_, were_VBD used_VBN for_IN PCR_NP detection_NN ._SENT Primers_NNS LGH4930_NP (_( 5'-TTCGCCTGTTAGACGAAGC-3_NP '_POS )_) and_CC LGH4929_NP (_( 5'-GATTCGCAAGCTTCAGTCTCGGAAGTAATTACG-3_NP '_POS )_) ,_, specific_JJ for_IN RTA_NP coding_VBG region_NN aa_NN 591_CD to_TO 691_CD ,_, were_VBD used_VBN as_IN negative_JJ control_NN to_TO detect_VB a_DT nonpromoter_NN region_NN ._SENT The_DT PCR_NP products_NNS were_VBD analyzed_VBN on_IN a_DT 2_CD %_NN agarose_NN gel_NN ._SENT Extraction_NN of_IN total_JJ RNA_NP and_CC Northern_NP blot_NN assay_NN ._SENT |_SYM BCBL1_NP cells_NNS were_VBD induced_VBN with_IN TPA_NP ,_, and_CC total_JJ RNA_NP was_VBD isolated_VBN at_IN different_JJ time_NN points_NNS using_VBG Trizol_NP reagent_NN (_( GIBCO_NP BRL_NP )_) according_VBG to_TO the_DT manufacturer_NN 's_POS protocol_NN ._SENT RNA_NP samples_NNS (_( 30_CD mug_NN )_) were_VBD separated_VBN on_IN a_DT 1.2_CD %_NN formaldehyde_NN agarose_NN gel_NN in_IN 1x_NP morpholinopropanesulfonic_JJ acid_NN (_( MOPS_NNS )_) running_VBG buffer_NN and_CC transferred_VBN to_TO a_DT Nytran_NP nylon_NN membrane_NN (_( Schleicher_NP &_CC Schuell_NP )_) ._SENT Restriction_NN enzyme-released_JJ fragments_NNS containing_VBG C/EBPalpha_NP (_( aa_NN 251_CD to_TO 358_CD )_) ,_, KSHV_NP RTA_NP (_( aa_NN 244_CD to_TO 548_CD )_) or_CC KSHV_NP RAP_NP (_( aa_NN 1_CD to_TO 237_CD )_) ,_, as_RB well_RB as_IN a_DT PCR-generated_JJ fragment_NN containing_VBG a_DT 286-bp_JJ GAPDH_NP (_( glyceraldehyde-3-phosphate_NN dehydrogenase_NN )_) cDNA_NN region_NN ,_, were_VBD labeled_VBN using_VBG the_DT Prime-a-Gene_NN labeling_VBG system_NN (_( Promega_NP )_) in_IN a_DT 50-mul_NP reaction_NN mixture_NN containing_VBG 1x_NN labeling_VBG buffer_NN ,_, 20_CD muM_NN concentrations_NNS of_IN dATP_NN ,_, dGTP_NN ,_, and_CC dTTP_NN ,_, 25_CD ng_NNS of_IN denatured_VBN DNA_NN template_NN ,_, 20_CD mug_NN of_IN bovine_JJ serum_NN albumin_NN ,_, 333_CD nM_NN [_SYM alpha-32P]dCTP(3,000_NP Ci/mmol_NP )_) ,_, and_CC 5_CD U_NN of_IN Klenow_NP DNA_NP polymerase_NN ._SENT After_IN end_NN labeling_VBG at_IN 20C_JJ for_IN 60_CD min_NN ,_, the_DT probes_NNS were_VBD purified_VBN with_IN Sephadex_NP G-50_NP ,_, denatured_VBD ,_, and_CC incubated_VBD with_IN the_DT membrane_NN in_IN a_DT hybridization_NN mixture_NN (_( 5_CD ml_NN )_) containing_VBG 50_CD %_NN formamide_NN ,_, 5x_NP SSC_NP (_( 1x_NP SSC_NP is_VBZ 0.15_CD M_NP NaCl_NP plus_CC 0.015_CD M_NP sodium_NN citrate_NN )_) ,_, 1x_NP Denhardt_NP 's_POS solution_NN ,_, 20_CD mM_NP NaPO4_NP (_( pH_NN 6.5_CD )_) ,_, 10_CD %_NN dextran_NN sulfate_NN ,_, and_CC calf_NN thymus_NN DNA_NN (_( 100_CD mug/ml_NN )_) ._SENT Sequential_JJ hybridizations_NNS were_VBD carried_VBN out_RP overnight_RB at_IN 42C_JJ ,_, and_CC the_DT membrane_NN was_VBD washed_VBN twice_RB in_IN 2x_JJ SSC-0.1_NP %_NN sodium_NN dodecyl_NN sulfate_NN (_( SDS_NP )_) at_IN room_NN temperature_NN and_CC then_RB twice_RB in_IN 0.5x_NP SSC-0.1_NP %_NN SDS_NP at_IN 50C_NP before_IN autoradiography_NN and_CC reuse_NN ._SENT For_IN an_DT RNA_NP loading_NN control_NN ,_, the_DT membrane_NN was_VBD stripped_VBN again_RB and_CC reprobed_VBN with_IN GAPDH_NP cDNA_NN ._SENT Protein_NN isolation_NN and_CC Western_JJ immunoblot_NN assay_NN ._SENT |_SYM Approximately_RB 107_CD BCBL1_JJ cells_NNS or_CC 106_CD 293T_JJ cells_NNS were_VBD harvested_VBN at_IN different_JJ time_NN points_NNS after_IN TPA_NP induction_NN or_CC at_IN 48_CD h_NN posttransfection_NN ,_, respectively_RB ;_: washed_VBD one_CD time_NN with_IN phosphate-buffered_JJ saline_NN ;_: gently_RB resuspended_JJ in_IN 0.2_CD ml_NN of_IN ice-cold_JJ immunoprecipitation_NN buffer_NN (_( 50_CD mM_NP Tris-Cl_NP [_SYM pH_NN 7.9_CD ]_SYM ,_, 50_CD mM_NP NaCl_NP ,_, 0.1_CD mM_NP EDTA_NP ,_, 1_CD %_NN glycerol_NN ,_, 0.2_CD %_NN NP-40_NP ,_, 1_CD mM_NP dithiothreitol_NN ,_, 0.5_CD mM_NP phenylmethylsulfonyl_NN fluoride_NN )_) ;_: and_CC sonicated_VBN for_IN 30_CD s._NN The_DT samples_NNS were_VBD then_RB centrifuged_VBN at_IN 15,000_CD x_NN g_NN for_IN 5_CD min_NN at_IN 4C_JJ ,_, and_CC the_DT supernatants_NNS were_VBD collected_VBN ._SENT Western_JJ blot_NN analysis_NN was_VBD performed_VBN after_IN SDS-polyacrylamide_NP gel_NN electrophoresis_NN ,_, using_VBG 10_CD mul_NN of_IN each_DT protein_NN sample_NN ._SENT The_DT proteins_NNS were_VBD detected_VBN by_IN immunoblotting_VBG with_IN rabbit_NN polyclonal_JJ antiserum_NN against_IN C/EBPalpha_NP ,_, KSHV_NP RTA_NP ,_, or_CC KSHV_NP RAP_NP or_CC mouse_NN MAb_NN against_IN Flag_NP as_RB described_VBD previously_RB ._SENT C/EBPalpha_NP activates_VBZ the_DT RTA_NP IE_NP promoter_NN in_IN cooperation_NN with_IN KSHV_NP RTA_NP and_CC RAP_NP ._SENT |_SYM Previous_JJ reports_NNS indicated_VBD that_IN cotransfected_JJ RTA_NP (_( ORF50_NP )_) autostimulates_VBZ expression_NN from_IN a_DT target_NN RTA_NP promoter_NN by_IN 40-fold_NN in_IN 293T_JJ cells_NNS using_VBG a_DT large_JJ RTA(-3000/+20)-LUC_NP reporter_NN gene_NN or_CC by_IN 6-fold_NN in_IN 293L_JJ cells_NNS using_VBG a_DT shorter_JJR RTA(-914/+34)-LUC_NP reporter_NN gene_NN ._SENT In_IN the_DT latter_JJ study_NN ,_, OCT1_JJ binding_NN to_TO the_DT RTA_NP promoter_NN was_VBD suggested_VBN to_TO be_VB important_JJ for_IN RTA_NP autoactivation_NN ,_, although_IN OCT1_NP had_VBD little_JJ effect_NN on_IN RTA_NP expression_NN when_WRB transfected_VBN alone_RB ._SENT We_PP suspected_VBD that_IN C/EBPalpha_NP might_MD also_RB be_VB involved_VBN in_IN the_DT efficient_JJ activation_NN of_IN RTA_NP gene_NN expression_NN during_IN the_DT KSHV_NP lytic_JJ cycle_NN ._SENT Exogenously_RB introduced_VBN C/EBPalpha_NP activates_VBZ expression_NN of_IN the_DT KSHV_NP DE_NP gene_NN RAP_NP (_( K8_NP )_) protein_NN in_IN PELs_NP and_CC cooperates_VBZ with_IN both_DT RTA_NP and_CC the_DT RAP_NP protein_NN itself_PP to_TO stimulate_VB the_DT RAP_NP promoter_NN in_IN transient-cotransfection_NN assays_NNS ._SENT Those_DT studies_NNS also_RB revealed_VBD that_IN the_DT C/EBPalpha_NP and_CC RTA_NP proteins_VBZ physically_RB interact_VB with_IN each_DT other_JJ (_( as_RB well_RB as_IN with_IN RAP_NP )_) ,_, but_CC whether_IN these_DT two_CD transcription_NN factors_NNS regulate_VB each_DT other_JJ 's_POS expression_NN at_IN the_DT transcriptional_JJ level_NN was_VBD not_RB known_VBN ._SENT Initially_RB ,_, we_PP transfected_VBD the_DT RTA(-914/+34)-LUC_NP target_NN reporter_NN gene_NN into_IN HeLa_NP cells_NNS and_CC tested_VBD the_DT effects_NNS of_IN cotransfected_JJ C/EBPalpha_NP ,_, RTA_NP ,_, and_CC RAP_NP effector_NN genes_NNS on_IN RTA_NP promoter_NN expression_NN ._SENT Only_RB 2.3-fold_JJ autoactivation_NN by_IN RTA_NP alone_RB was_VBD observed_VBN ._SENT However_RB ,_, C/EBPalpha_NP alone_RB gave_VBD a_DT 15-fold_NN stimulation_NN of_IN RTA-LUC_NP activity_NN ,_, and_CC addition_NN of_IN RTA_NP and_CC C/EBPalpha_NP together_RB resulted_VBD in_IN further_JJR enhancement_NN up_RP to_TO 31-fold_NN ._SENT Although_IN RAP_NP had_VBD no_DT effect_NN on_IN RTA_NP promoter_NN activity_NN when_WRB transfected_VBN alone_RB (_( 1.1-fold_NN )_) ,_, cotransfection_NN of_IN RAP_NP and_CC RTA_NP together_RB resulted_VBD in_IN up_RB to_TO 14-fold_NN activation_NN in_IN the_DT absence_NN of_IN C/EBPalpha_NP ._SENT When_WRB cotransfected_VBN with_IN C/EBPalpha_NP ,_, RAP_NP also_RB elevated_VBD the_DT level_NN of_IN transactivation_NN by_IN a_DT factor_NN of_IN 2_CD up_RB to_TO 30-fold_NN ._SENT To_TO confirm_VB these_DT observations_NNS about_IN transactivation_NN of_IN the_DT RTA_NP promoter_NN in_IN the_DT physiologically_RB more_RBR relevant_JJ B_NN cells_NNS ,_, the_DT cotransfection_NN experiments_NNS were_VBD also_RB carried_VBN out_RP in_IN the_DT KSHV-_NP and_CC EBV-negative_NP DG75_NP lymphoblast_NN cell_NN line_NN by_IN electroporation_NN ._SENT C/EBPalpha_NP alone_RB induced_VBD RTA-LUC_NP expression_NN up_RB to_TO 8.1-fold_NN (_( 10_CD mug_NN )_) ,_, but_CC again_RB ,_, although_IN RTA_NP only_RB autoactivated_VBD its_PP$ promoter_NN by_IN 2.1-fold_JJ (_( 10_CD mug_NN )_) ,_, it_PP more_RBR than_IN additively_RB increased_VBN the_DT activation_NN by_IN C/EBPalpha_NP ,_, from_IN 6.5-fold_NN up_RP to_TO 14-fold_NN at_IN the_DT 5-mug_JJ input_NN DNA_NN level_NN ._SENT Addition_NN of_IN RAP_NP also_RB enhanced_VBD both_DT C/EBPalpha_NP and_CC RTA_NP activation_NN levels_NNS nearly_RB twofold_RB ._SENT Finally_RB ,_, when_WRB C/EBPalpha_NP ,_, RTA_NP ,_, and_CC RAP_NP were_VBD all_RB added_VBN together_RB to_TO the_DT transfection_NN (_( 5_CD mug_NN each_DT )_) ,_, the_DT strongest_JJS level_NN of_IN activation_NN was_VBD obtained_VBN (_( 18-fold_NN )_) ._SENT Therefore_RB ,_, C/EBPalpha_NP proved_VBD to_TO be_VB the_DT most_RBS significant_JJ activator_NN of_IN the_DT RTA_NP promoter_NN discovered_VBD so_RB far_RB ,_, and_CC just_RB as_RB for_IN the_DT RAP_NP promoter_NN ,_, KSHV_NP RTA_NP and_CC RAP_NP cooperated_VBD with_IN C/EBPalpha_NP to_TO achieve_VB the_DT highest_JJS level_NN of_IN activation_NN ._SENT Transfection_NN by_IN C/EBPalpha_NP increases_VBZ the_DT level_NN of_IN RTA_NP mRNA_NP in_IN PEL_NP cells_NNS ._SENT |_SYM The_DT cotransfection_NN data_NNS above_RB strongly_RB suggest_VBP that_IN C/EBPalpha_NP is_VBZ capable_JJ of_IN upregulating_VBG KSHV_NP RTA_NP expression_NN at_IN the_DT transcriptional_JJ level_NN ._SENT To_TO ask_VB whether_IN this_DT effect_NN can_MD be_VB demonstrated_VBN to_TO occur_VB in_IN vivo_JJ in_IN KSHV-infected_NP PEL_NP cells_NNS ,_, we_PP performed_VBD RT-PCR_NP in_IN C/EBPalpha-transfected_NP BCBL1_NP cells_NNS ._SENT The_DT mRNA_NN samples_NNS were_VBD isolated_VBN and_CC treated_VBN with_IN DNase_NP I_NP to_TO eliminate_VB genomic_JJ DNA_NN contamination_NN before_IN RT_NP was_VBD carried_VBN out_RP ._SENT After_IN cDNA_NN synthesis_NN ,_, two_CD primers_NNS specific_JJ for_IN the_DT RTA_NP gene_NN were_VBD used_VBN for_IN PCR_NP amplification_NN ,_, giving_VBG an_DT expected_VBN product_NN of_IN 915_CD bp_NN In_IN empty_JJ vector-transfected_JJ control_NN cells_NNS ,_, the_DT level_NN of_IN RTA_NP mRNA_NP detected_VBD was_VBD very_RB low_JJ (_( Fig._NN ,_, lane_NN 2_CD )_) ;_: however_RB ,_, TPA_NP treatment_NN for_IN 24_CD h_NN resulted_VBN in_IN the_DT activation_NN of_IN KSHV_NP lytic_JJ replication_NN in_IN 15_CD %_NN of_IN the_DT cells_NNS (_( as_RB detected_VBN by_IN IFA_NP for_IN RAP_NP )_) and_CC led_VBN to_TO a_DT 12-fold_NN increase_NN in_IN the_DT level_NN of_IN RTA_NP mRNA_NP (_( Fig._NN ,_, lane_NN 3_CD )_) ._SENT In_IN BCBL1_JJ cells_NNS electroporated_VBN with_IN C/EBPalpha_NP expression_NN plasmid_NP DNA_NP ,_, the_DT RTA_NP mRNA_NN level_NN increased_VBN by_IN 6.7-fold_NN compared_VBN to_TO empty_VB vector-transfected_JJ cells_NNS ,_, whereas_IN there_EX was_VBD no_DT effect_NN on_IN RTA_NP expression_NN in_IN RAP-transfected_JJ cells_NNS (_( Fig._NN ,_, lanes_NNS 4_CD and_CC 5_CD )_) ._SENT In_IN BCBL1_JJ cells_NNS cotransfected_VBN with_IN both_DT C/EBPalpha_NP and_CC RAP_NP ,_, there_EX was_VBD a_DT small_JJ additive_JJ increase_NN in_IN the_DT expression_NN of_IN RTA_NP mRNA_NP (_( 7.8-fold_NN )_) compared_VBN to_TO cells_NNS transfected_VBN with_IN C/EBPalpha_NP alone_RB (_( Fig._NN ,_, lane_NN 6_CD )_) ._SENT Authentication_NN of_IN the_DT expected_VBN size_NN of_IN the_DT RT-PCR_NP product_NN was_VBD provided_VBN using_VBG RNA_NP from_IN BCBL1_NP cells_NNS transfected_VBN with_IN an_DT RTA_NP cDNA_NN expression_NN plasmid_NP (_( Fig._NN ,_, lane_NN 7_CD )_) ;_: however_RB ,_, any_DT effect_NN of_IN RTA_NP on_IN autoactivation_NN here_RB was_VBD unable_JJ to_TO be_VB detected_VBN because_IN both_DT endogenous_JJ RTA_NP expression_NN and_CC the_DT transfected_JJ RTA_NP plasmid_NP give_VBP RT-PCR_NP products_NNS of_IN the_DT same_JJ size_NN ._SENT Introduction_NN of_IN C/EBPalpha_NP induces_VBZ endogenous_JJ RTA_NP protein_NN expression_NN in_IN PEL_NP cells_NNS ._SENT |_SYM To_TO confirm_VB that_DT RTA_NP protein_NN expression_NN can_MD be_VB induced_VBN by_IN C/EBPalpha_NP ,_, double-label_NP IFA_NP experiments_NNS were_VBD performed_VBN with_IN CMV-Flag-C/EBPalpha_NP transfected_VBD latently_RB infected_JJ BCBL1_JJ cells_NNS ._SENT Expression_NN of_IN endogenous_JJ RTA_NP protein_NN was_VBD absent_JJ in_IN empty_JJ vector-transfected_JJ control_NN cells_NNS (_( Fig._NN to_TO C_NP )_) ;_: however_RB ,_, in_IN C/EBPalpha-transfected_JJ cells_NNS ,_, 37_CD %_NN of_IN the_DT cells_NNS that_WDT expressed_VBD exogenous_JJ Flag-tagged_NP C/EBPalpha_NP were_VBD also_RB now_RB positive_JJ for_IN RTA_NP (_( Fig._NN to_TO F_NP )_) ._SENT In_IN comparison_NN ,_, transfection_NN with_IN SV2-Flag-RAP_NP did_VBD not_RB induce_VB RTA_NP protein_NN expression_NN in_IN any_DT of_IN the_DT RAP-positive_JJ cells_NNS as_IN detected_VBN by_IN anti-Flag_NP MAb_NP and_CC anti-RTA_NP PAb_NP (_( Fig._NN G_NN to_TO I_PP )_) ._SENT Interestingly_RB ,_, in_IN BCBL1_JJ cells_NNS doubly_RB transfected_VBN with_IN CMV-C/EBPalpha_NP and_CC SV2-Flag-RAP_NP ,_, 51_CD %_NN of_IN RAP-positive_JJ cells_NNS became_VBD positive_JJ for_IN RTA_NP protein_NN expression_NN ._SENT Additional_JJ IFA_NP experiments_NNS confirmed_VBD that_IN more_JJR than_IN 95_CD %_NN of_IN cells_NNS expressing_VBG either_RB one_CD of_IN the_DT transfected_JJ effector_NN plasmids_NNS in_IN the_DT double-transfection_NN experiments_NNS were_VBD positive_JJ for_IN expression_NN of_IN both_DT proteins_NNS (_( data_NNS not_RB shown_VBN )_) ._SENT Therefore_RB ,_, expression_NN of_IN exogenous_JJ C/EBPalpha_NP alone_RB can_MD activate_VB RTA_NP expression_NN from_IN a_DT latent_JJ state_NN in_IN some_DT cells_NNS and_CC RAP_NP can_MD evidently_RB augment_VB C/EBPalpha-mediated_JJ transactivation_NN of_IN the_DT RTA_NP promoter_NN ,_, although_IN it_PP has_VBZ no_DT effect_NN alone_RB ._SENT Identification_NN of_IN three_CD C/EBP_NP binding_JJ sites_NNS in_IN the_DT RTA_NP promoter_NN ._SENT |_SYM DNA_NP sequence_NN analysis_NN revealed_VBD five_CD potential_JJ C/EBP_NP binding_JJ sites_NNS within_IN the_DT RTA_NP promoter_NN region_NN between_IN positions_NNS -914_CD and_CC +20_NN ._SENT Complementary_JJ oligonucleotide_NN pairs_NNS (_( 37_CD nucleotides_NNS long_RB )_) containing_VBG each_DT of_IN these_DT putative_JJ sites_NNS (_( designated_VBN as_IN RP-1_NP to_TO RP-5_NP )_) were_VBD synthesized_VBN ,_, annealed_VBN ,_, and_CC 32P-labeled_JJ as_IN probes_NNS for_IN EMSA_NP to_TO test_VB their_PP$ affinity_NN for_IN C/EBPalpha_NP protein_NN ._SENT Strong_JJ EMSA_NP bands_NNS were_VBD observed_VBN with_IN probes_NNS RP-1_NP and_CC RP-3_NP when_WRB in_IN vitro-translated_JJ C/EBPalpha_NP protein_NN was_VBD added_VBN (_( Fig._NN ,_, lanes_NNS 2_CD and_CC 8_CD )_) ,_, and_CC the_DT addition_NN of_IN antibody_NN against_IN C/EBPalpha_NP resulted_VBD in_IN the_DT formation_NN of_IN typical_JJ slower-migrating_JJ supershifted_JJ bands_NNS (_( Fig._NN ,_, lanes_NNS 3_CD and_CC 9_CD )_) ._SENT Low-affinity_NN binding_VBG to_TO the_DT C/EBPalpha_NP protein_NN was_VBD also_RB observed_VBN with_IN probe_NN RP-5_NP (_( Fig._NN ,_, lanes_NNS 14_CD and_CC 15_CD )_) ,_, but_CC neither_DT probe_NN RP-2_NP nor_CC RP-4_NP showed_VBD any_DT affinity_NN for_IN C/EBPalpha_NP ,_, and_CC a_DT triple-point_NN mutation_NN introduced_VBN into_IN RP-5_NP M_NP destroyed_VBD its_PP$ ability_NN to_TO bind_VB C/EBPalpha_NP (_( Fig._NN ,_, lanes_NNS 17_CD and_CC 18_CD )_) ._SENT The_DT three_CD putative_JJ C/EBP_NP sites_NNS that_WDT proved_VBD to_TO interact_VB with_IN C/EBPalpha_NP in_IN vitro_NP were_VBD designated_VBN C/EBP-I_NP (_( within_IN probe_NN RP-1_NP )_) ,_, C/EBP-II_NP (_( within_IN probe_NN RP-3_NP )_) ,_, and_CC C/EBP-III_NP (_( within_IN probe_NN RP-5_NP )_) ._SENT To_TO examine_VB the_DT contribution_NN of_IN these_DT sites_NNS to_TO the_DT transactivation_NN of_IN the_DT RTA_NP promoter_NN by_IN C/EBPalpha_NP ,_, we_PP constructed_VBD a_DT series_NN of_IN deletion_NN mutants_NNS with_IN 5_CD '_POS boundaries_NNS at_IN positions_NNS -587_CD ,_, -554_CD ,_, -261_CD ,_, -241_CD ,_, and_CC -212_CD that_WDT sequentially_RB removed_VBD the_DT C/EBP-I_NP and_CC C/EBP-II_NP sites_NNS from_IN the_DT full-length_JJ RTA(-914/+34)-LUC_NP reporter_NN gene_NN ,_, as_RB illustrated_VBN in_IN Fig._NN ._SENT In_IN addition_NN ,_, the_DT same_JJ mutated_VBN version_NN of_IN C/EBP-III_NP that_WDT was_VBD generated_VBN in_IN RP-5M_NP was_VBD introduced_VBN into_IN both_DT RTA(-587/+20)-LUC_NP and_CC RTA(-241/+20)-LUC_NP ._SENT The_DT responsiveness_NN of_IN each_DT of_IN these_DT truncated_JJ RTA_NP reporter_NN genes_NNS to_TO cotransfection_NN with_IN increasing_VBG doses_NNS of_IN C/EBPalpha_NP effector_NN plasmid_NP DNA_NP was_VBD measured_VBN ,_, and_CC the_DT results_NNS are_VBP summarized_VBN in_IN the_DT histogram_NN shown_VBN in_IN Fig._NN ._SENT Basal_JJ activity_NN across_IN the_DT series_NN did_VBD not_RB change_VB by_IN more_JJR than_IN 50_CD %_NN and_CC is_VBZ not_RB included_VBN in_IN the_DT data_NNS ._SENT Only_RB the_DT mutant_JJ version_NN of_IN RTA(-241/+20)-LUC_NP without_IN any_DT of_IN the_DT three_CD identified_VBN C/EBP_NP sites_NNS remaining_VBG showed_VBN a_DT fourfold_JJ reduction_NN ,_, with_IN all_DT of_IN the_DT others_NNS giving_VBG less_JJR than_IN twofold_JJ reduction_NN in_IN responsiveness_NN to_TO C/EBPalpha_NP alone_RB ._SENT Therefore_RB ,_, evidently_RB both_CC the_DT C/EBP-II_NP and_CC C/EBP-III_NP sites_NNS alone_RB are_VBP sufficient_JJ for_IN direct_JJ C/EBPalpha_NP activation_NN ._SENT We_PP also_RB examined_VBD the_DT role_NN of_IN the_DT C/EBP_NP binding_JJ sites_NNS in_IN cooperative_JJ activation_NN by_IN C/EBPalpha_NP plus_CC RTA_NP and_CC RAP_NP ._SENT Deletion_NN of_IN C/EBP-I_NP in_IN RTA(-554/+20)-LUC_NP led_VBD to_TO partial_JJ impairment_NN of_IN enhanced_JJ C/EBPalpha_NP activation_NN by_IN both_DT RTA_NP and_CC RAP_NP ,_, whereas_IN when_WRB C/EBP-II_NP was_VBD also_RB deleted_VBN in_IN RTA(-241/+20)-LUC_NP ,_, cooperativity_NN between_IN RTA_NP and_CC RAP_NP with_IN C/EBPalpha_NP was_VBD nearly_RB abolished_VBN ._SENT However_RB ,_, although_IN mutation_NN of_IN C/EBP-III_NP in_IN RTA(-241/+20_NP pm-48/-43)-LUC_NP significantly_RB impaired_VBD direct_JJ C/EBPalpha_NP activation_NN ,_, the_DT cooperative_JJ enhancement_NN by_IN RTA_NP and_CC RAP_NP was_VBD not_RB affected_VBN ._SENT Therefore_RB ,_, either_CC one_CD or_CC both_DT of_IN the_DT C/EBP-I_NP and_CC -II_NP sites_NNS that_WDT bind_VBP strongly_RB to_TO C/EBPalpha_NP protein_NN in_IN EMSA_NP appear_VBP to_TO be_VB required_VBN for_IN the_DT cooperative_JJ activation_NN by_IN C/EBPalpha_NP ,_, RTA_NP ,_, and_CC RAP_NP ,_, with_IN C/EBP-II_NP alone_RB being_VBG sufficient_JJ and_CC C/EBP-III_NP not_RB contributing_VBG ._SENT In_IN parallel_JJ experiments_NNS ,_, neither_CC deletion_NN nor_CC point_NN mutation_NN of_IN the_DT OCT1_JJ site_NN (_( -220/-213_LS )_) described_VBN by_IN others_NNS had_VBD any_DT significant_JJ effect_NN on_IN basal_JJ activity_NN or_CC on_IN C/EBPalpha_NP or_CC RTA_NP transactivation_NN in_IN our_PP$ studies_NNS in_IN HeLa_NP or_CC DG75_NP cells_NNS (_( data_NNS not_RB shown_VBN )_) ._SENT A_DT recent_JJ study_NN by_IN Saveliev_NP et_FW al._FW suggests_VBZ that_IN the_DT KSHV_NP RTA_NP promoter_NN region_NN may_MD initiate_VB a_DT second_JJ set_NN of_IN IE_NP transcripts_NNS in_IN a_DT bidirectional_JJ fashion_NN from_IN near_JJ position_NN -100_CD and_CC that_IN in_IN addition_NN a_DT minor_JJ IE_NP version_NN of_IN RAP_NP mRNA_NP may_MD initiate_VB from_IN position_NN -250_CD in_IN the_DT KSHV_NP RAP_NP promoter_NN ._SENT If_IN so_RB ,_, the_DT C/EBP-III_NP site_NN described_VBN here_RB would_MD still_RB represent_VB an_DT upstream_JJ regulator_NN for_IN both_CC the_DT spliced_VBN RTA_NP (_( ORF50_NP )_) and_CC ORF48/19_NP IE_NP transcripts_NNS ,_, but_CC C/EBP-I_NP and_CC -II_NP would_MD be_VB downstream_JJ and_CC possible_JJ negative_JJ regulators_NNS of_IN the_DT ORF48/29_NP leftward_RB spliced_VBD IE_NP transcript_NN ._SENT Similarly_RB ,_, the_DT overlapping_JJ C/EBP-RRE_NP motif_NN in_IN the_DT RAP_NP promoter_NN would_MD be_VB downstream_JJ of_IN the_DT minor_JJ IE_NP RAP_NP transcription_NN start_NN site_NN and_CC would_MD likely_RB have_VB negative_JJ regulatory_JJ effects_NNS compared_VBN to_TO the_DT positive_JJ effects_NNS observed_VBN on_IN the_DT predominant_JJ DE_NN version_NN of_IN the_DT RAP_NP promoter_NN that_IN we_PP worked_VBD with_IN previously_RB ._SENT C/EBPalpha_NP ,_, RTA_NP ,_, and_CC RAP_NP all_DT associate_NN with_IN the_DT RTA_NP promoter_NN in_IN vivo_JJ by_IN ChIP_NP assay_NN ._SENT |_SYM ChIP_NP assays_NNS provide_VBP a_DT powerful_JJ method_NN to_TO investigate_VB the_DT as_IN 